Akebia Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$1.41

+0.05 (+3.68%)

As of Mar 25, 3:06 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +2,556.0% upside

Low Target $22.27

Average Target $37.45

High Target $46.32

Current Price $1.41

Current
$1.41

Target
$37.45

$22.27 $37.45 avg $46.32

Scenario Analysis

Bear Case

$22.27

1,479.4%

Low target

Base Case

$37.45

+2,556.0%

Avg target

Bull Case

$46.32

+3,185.1%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$4.08

-65.4% from high

52-Week Low

$1.14

+23.7% from low

Target vs 52W High

$37.45

+818.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%